Gregory Weinhoff
Chief Financial Officer
Bioharmaceuticals
Roivant Sciences
Switzerland
Biography
Gregory Weinhoff has more than twenty years of experience in healthcare finance and operations, including as a venture capital investor, operating executive, and board member with Audit Committee experience. Prior to joining Axovant, Dr. Weinhoff served as Partner at CHL Medical Partners focused on investments into start-up and early-stage companies across therapeutics, diagnostics, medical devices, and healthcare services. He was also the founding CEO of Amicus Therapeutics (NASDAQ: FOLD), and subsequently a member of the company board Audit Committee. Dr. Weinhoff was the founding President of VaxInnate and the President of Resolvyx, and he served in healthcare groups at J.H. Whitney & Co. and Morgan Stanley & Co. He received his M.D. from Harvard Medical School, his M.B.A. from Harvard Business School (Baker Scholar), and his A.B. in Economics (magna cum laude) from Harvard College
Research Interest
Economics
